| ¿µ¹® | malabsorption | ÇÑ±Û | Èí¼öÀå¾Ö |
|---|---|---|---|
| ¼³¸í | Àå°ü¿¡¼ ¿µ¾ç¼Ò°¡ Ç÷¾×À¸·Î Àß Èí¼öµÇÁö ¾Ê´Â Çö»ó. ÀÛÀºÃ¢ÀÚ¿¡¼ ¿µ¾ç¼Ò°¡ ÀϺΠ¶Ç´Â ÀüºÎ Èí¼öµÇÁö ¾Ê¾Æ »ý±â´Â º´À» ¸»ÇÑ´Ù. ÀÌ º´Àº ´ëºÎºÐ ¸Å¿ì õõÈ÷ ¹ßº´µÇ±â ½ÃÀÛÇÏ¿© Áø´ÜÇϱⰡ ¸Å¿ì ¾î·Á¿ì¸ç, º´À» ÀǽÄÇϱâ ÀüÀÇ ¼ö°³¿ù¿¡¼ ¼ö³â µ¿¾È ÁøÇàµÇ´Â °æ¿ìµµ ÀÖ´Ù. Àå±â°£ Ä¡·áÇØ¾ß Çϸç, Ä¡·á¹æ¹ý º¹ÀâÇϰí ÀÚÁÖ ¹Ù²ð ¼ö ÀÖ´Ù. ³²-³à ¸ðµÎ ºñ½ÁÇÑ ºñÀ²·Î ¸ðµç ¿¬·ÉÃþ¿¡¼ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ¿øÀÎÀº ù°, 1Â÷Àû ¼±ÃµÀû ÀÌ»óÀ¸·Î¼ Á¥´ç-¼³´ç µî ÀÌ´ç·ù ºÐÇØ È¿¼ÒÀÇ °áÇÌ, ÀÌÀÚ-ÀÛÀºÃ¢ÀÚ µîÀÇ ¼ÒÈÈ¿¼Ò °áÇÌ, Æ÷µµ´ç°ú ºñŸ¹Î B12 µî ÀÛÀºÃ¢ÀÚ Á¡¸·ÀÇ Àü¼ÛÀå¾Ö µîÀ» µé ¼ö ÀÖ´Ù. µÑ°, 2Â÷Àû ¿øÀÎÀ¸·Î¼ âÀÚº´ µîÀ¸·Î °è¼Ó Èí¼öºÒ·®ÀÌ ÀϾ´Â °æ¿ìÀÌ´Ù. ÀÌ ¹Û¿¡ âÀÚ°ü ³»ÀÇ È¿¼Ò°¡ ºÎÁ·Çϰųª Á¤»ó »óÅÂÀÇ Ã¢ÀÚº´ ¼¼±ÕÀÌ º¯ÇÏ´Â °æ¿ì, ÀÌÀÚ-°£-¾µ°³ µîÀÇ º´À¸·Î ¼ÒȰ¡ Àß µÇÁö ¾Ê´Â °æ¿ì, ±â»ýÃæ-º¹Åë µî âÀÚ°ü º®ÀÇ º´ÀÌ ÀÖ´Â °æ¿ì, âÀÚ°üÀýÁ¦ ¼ö¼ú·Î Èí¼ö ¸éÀûÀÌ ÁÙ¾úÀ» °æ¿ì µîÀ» µé ¼ö ÀÖ´Ù. À§Çè ÀÎÀڷδ ¾ËÄÚ¿Ã °ú´Ù¼·Ãë, âÀÚ°ü¼ö¼ú, °¡Á· Áß Èí¼öºÒ·®À̳ª ³¶Æ÷¼º¼¶À¯Áõ ȯÀÚ°¡ ÀÖ´Â °æ¿ì, ±¤À¯ ¶Ç´Â ´Ù¸¥ ¿ÏÇÏÁ¦¸¦ »ç¿ëÇÑ °æ¿ì µîÀÌ ÀÖ´Ù. Áõ¼¼´Â ½Ä¿åºÎÁø-ºÒÄè°¨-üÁß°¨¼Ò-¼³»ç-º¹ºÎÆØ¸¸ µîÀÌ ³ªÅ¸³ª°í, ´Ü¹éÁú-Áö¹æ-ºñŸ¹Î µîÀÇ Èí¼öºÒ·®À¸·Î °¢°¢ÀÇ °áÇÌÁõ¼¼°¡ ³ªÅ¸³´Ù. ´Ü¹éÁú °áÇÌ¿¡ ÀÇÇØ¼ À¯¾ÆÀÇ ¹ßÀ°ºÎÁø, ºóÇ÷, Àú¾ËºÎ¹ÎÇ÷Áõ, ºÎÁ¾ µîÀÌ »ý±â¸ç, ºñŸ¹Î DÀÇ Èí¼öÀå¾Ö·Î ÀÎÇÏ¿© »ÀÀÇ ¹ßÀ°¿¡ ¹®Á¦°¡ »ý±ä´Ù. ºñŸ¹Î K¿Í B12ÀÇ Èí¼öÀå¾Ö·Î ÃâÇ÷°ú °Å´ëÀû¸ð±¸¼ººóÇ÷ÀÌ »ý±â°í, ÀÛÀºÃ¢ÀÚ Á¡¸·ÀÇ Æ÷µµ´ç°ú °¥¶ôÅä¿À½ºÀÇ Àü¼Û Àå¾Ö·Î ÀÎÇØ ¼³»ç-ÀúÇ÷´ç-¿µ¾çÀå¾Ö µîÀÌ ³ªÅ¸³´Ù. ¶ÇÇÑ ¹«±â·Â°ú °æ¹ÌÇÑ ºóÇ÷ µîÀÌ ³ªÅ¸³ª°í, º¹ºÎ¿¡ °¡½º°¡ Â÷°Å³ª ¸·¿¬È÷ ºÒÆíÇϸç, ´ëº¯ÀÇ ³¿»õ°¡ ³ª»Ú°í ¾çÀÌ ¸¹´Ù. ÇÕº´ÁõÀ¸·Î ¼ÒȺҷ®ÀÌ Àå±â°£ Áö¼ÓµÇ°Å³ª À¯¾ÆÀÇ °æ¿ì »ç¸ÁÇÒ ¼ö ÀÖÀ¸¸ç, ¿µ¾ç¼Ò-ºñŸ¹Î-¹«±âÁú °áÇÌ µîÀ¸·Î ÀÎÇÏ¿© ´Ù¸¥ ÁúȯÀÌ »ý±æ ¼öµµ ÀÖ´Ù. |
||
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
|---|---|
| GGM | glucose-galactose malabsorption |
| LM | lactic acid mineral [medium]; lactose malabsorption; laryngeal mask; laryngeal muscle; lateral malle... |
| FABP | fatty acid-binding protein; folate-binding protein |
| FBP | femoral blood pressure; fibrin breakdown product; folate-binding protein; fructose-1, 6-biphosphatas... |
| FBP | Folate binding protein |
|---|---|
| FR | Folate receptor |
| FRalpha | Folate receptor alpha |
| RCF | Red cell folate |
| RFC | Reduced folate carrier |
| sodium folate | The sodium salt of folic acid; action and uses are the same as those of folic acid, but it is preferred for parenteral administration. Synonym: sodium pteroylglutamate. (05 Mar 2000) |
|---|---|
| folate | <biochemistry> Molecule that acts as a carrier of one carbon units in intermediary metabolism. It contains residues of p aminobenzoate, glutamate and a substituted pteridine. The latter cannot be synthesised by mammals, which must obtain tetrahydrofolate as a vitamin or from intestinal microorganisms. One carbon units are carried at three different levels of oxidation, as methyl, methylene or formimino groups. Important biosyntheses dependent on tetrahydrofolate include those of methionine, thymine and purines. Analogues of dihydrofolate, such as aminopterin and methotrexate block the action of tetrahydrofolate by inhibiting its regeneration from dihydrofolate. (18 Nov 1997) |
| folate antagonist | <pharmacology> One of a group of substances which blocks the formation of nucleotides that require the presence of folate (one of the B vitamins) before they can be made. The substance does this by blocking key steps in the reaction sequence. These substances are often used to treat cancer because fast-growing cancerous cells usually need to use the blocked reactions more than normal cells. (09 Oct 1997) |
| malabsorption | <gastroenterology> Impaired intestinal absorption of nutrients. (18 Nov 1997) |
| malabsorption syndrome | <syndrome> A variety of conditions in which digestion and absorption in the small intestine are impaired. Multiple causes including lymphoma, amyloid and other infiltrations, Crohn's disease, gluten sensitive enteropathy and the sprue syndrome in which the villi atrophy for unknown reasons. (18 Nov 1997) |
| malabsorption syndromes | General term for syndromes of malnutrition due to failure of normal intestinal absorption of nutrients. (12 Dec 1998) |
| methionine malabsorption syndrome | <syndrome> An inherited disorder in which there is an inability to absorb l-methionine from the gut. (05 Mar 2000) |
| intestinal malabsorption | <gastroenterology> The inadequate absorption of nutrients from the small intestine. This can result in loss of weight and abnormal appearing stools. Malabsorption can be caused by lesions of the small intestine, amyloidosis, lack of digestive enzymes (for example lactose intolerance) or bile salts or surgical operations. (10 Jan 1998) |
| Albright's hereditary osteodystrophy | An inherited form of hyperparathyroidism associated with ectopic calcification and ossification and skeletal defects, notably the small fourth metacarpals, but intelligence is normal. There are dominant, recessive and X-linked forms. See: pseudohypoparathyroidism. Synonym: Albright's syndrome. (05 Mar 2000) |
| angioedema, hereditary | A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema. (12 Dec 1998) |
| angioneurotic oedema, hereditary | A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema. (12 Dec 1998) |
| canine hereditary blindness | An autosomal dominant condition seen in dogs of the collie and several other breeds. (05 Mar 2000) |
| colourectal neoplasms, hereditary nonpolyposis | A syndrome characterised by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumours in the proximal colon. (12 Dec 1998) |
| corneal dystrophies, hereditary | Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect. (12 Dec 1998) |
| hereditary | <genetics> Transferred via genes from parent to child. (16 Dec 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|